Clinical Study Monitoring & CRA Services
Clinical Trial Monitoring and CRA Services for Phase I, Phase II and Phase III Clinical Trials
TCR-Solutions provides clinical study monitoring and CRA services for Phase I, Phase II, and Phase III clinical trials. As a UK CRO with global reach, we support sponsors with monitoring strategies designed to protect patient safety, maintain data quality and support regulatory compliance throughout the study lifecycle.
Our monitoring approach is built on a clear principle:
👉 Oversight should be proportionate, proactive, and focused on what matters most.
We deliver risk-based monitoring (RBM) strategies tailored to the complexity, phase and risk profile of each study. By combining on-site, remote, and centralised monitoring, we provide effective clinical trial oversight without unnecessary burden on sites or sponsors.
Our Clinical Study Monitoring & CRA services include:
• Development of risk-based monitoring plans, aligned with ICH GCP and study-specific risk profiles
• On-site monitoring visits, ensuring direct engagement with investigators and site teams
• Remote and centralised monitoring, enabling continuous oversight and efficient issue detection
• Source Data Verification (SDV) and Source Data Review (SDR)
• Investigator and site staff training, supporting protocol compliance
• Monitoring visit reports, follow-up actions, and issue escalation
• Close coordination with Project Management, Medical Monitoring, and Pharmacovigilance Services
Why Clinical Trial Monitoring Matters
Clinical trial monitoring plays a critical role in the successful delivery of Phase I, Phase II, and Phase III clinical trials, helping to ensure:
• Patient safety
• Data integrity and reliability
• Compliance with regulatory standards
Without effective monitoring, studies risk:
• Undetected protocol deviations
• Data inconsistencies
• Delayed issue resolution
• Increased regulatory risk
At TCR-Solutions, we provide proactive clinical study monitoring and CRA services that support:
• Early identification and resolution of study issues
• Improved site compliance and performance
• Efficient oversight through hybrid monitoring approaches
• Greater confidence in data quality for regulatory submission
Frequently Asked Questions
Do you offer remote monitoring?
Yes — we provide hybrid monitoring models that combine on-site, remote and centralised approaches According to study needs and risk profile.
Do you support Phase III clinical trials?
Yes — we support clinical study monitoring and CRA services across Phase I, Phase II and Phase IIII clinical trials including global studies.
What is included in your clinical study monitoring and CRA services?
Our services include risk-based monitoring plans, on-site monitoring visits, remote and centralised monitoring, SDV, SDR, site training, monitoring reports and issue escalation.